TAFA4 and adenocarcinoma: Subsequently, growing evidence demonstrated a progressive increase in FAM19A4 methylation levels in squamous cell carcinomas compared to CIN3 lesions, as well as in adenocarcinomas compared to adenocarcinomas in situ [25].